Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Abstract Neonatal hypoxic-ischaemic encephalopathy (HIE) is a serious condition; many survivors develop neurological impairments, including cerebral palsy and intellectual disability. Preclinical studies show that the systemic administration of umbilical cord blood cells (UCBCs) is beneficial for ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Masahiro Tsuji, Mariko Sawada, Shinichi Watabe, Hiroyuki Sano, Masayo Kanai, Emi Tanaka, Satoshi Ohnishi, Yoshiaki Sato, Hisanori Sobajima, Takashi Hamazaki, Rintaro Mori, Akira Oka, Hiroyuki Ichiba, Masahiro Hayakawa, Satoshi Kusuda, Masanori Tamura, Makoto Nabetani, Haruo Shintaku
Format: Artigo
Idioma:anglès
Publicat: 2020
Accés en línia:https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf

Ítems similars